SWOBY vs PFE: Which Stock is Better?
Side-by-side comparison of Swedish Orphan Biovitrum AB (publ) and Pfizer Inc in 2026
SWOBY
Swedish Orphan Biovitrum AB (publ)
$19.63
PFE
Pfizer Inc
$27.22
Key Metrics Comparison
| Metric | SWOBY | PFE | Winner |
|---|---|---|---|
| Market Cap | $14.20B | $154.67B | PFE |
| P/E Ratio | 280.39 | 19.99 | PFE |
| EPS (TTM) | $0.07 | $1.36 | PFE |
| Revenue Growth | 0.1% | -0.0% | SWOBY |
| Gross Margin | 78.2% | 75.8% | SWOBY |
Analyze SWOBY
Full quant analysis
Analyze PFE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SWOBY or PFE a better investment?
Comparing SWOBY and PFE: Swedish Orphan Biovitrum AB (publ) has a market cap of $14.20B while Pfizer Inc has $154.67B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SWOBY and PFE?
SWOBY (Swedish Orphan Biovitrum AB (publ)) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SWOBY or PFE?
Based on P/E ratios, PFE trades at a lower multiple (20.0x vs 280.4x).
Which is growing faster: SWOBY or PFE?
SWOBY has higher revenue growth at 0.1% vs -0.0% for PFE.
Which company is more profitable: SWOBY or PFE?
Swedish Orphan Biovitrum AB (publ) (SWOBY) has higher gross margins at 78.2% compared to 75.8% for PFE.
Which is the larger company: SWOBY or PFE?
Pfizer Inc (PFE) is larger with a market cap of $154.67B compared to $14.20B for SWOBY.
Should I buy SWOBY or PFE in 2026?
Both SWOBY and PFE have investment merit. SWOBY trades at $19.63 while PFE trades at $27.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SWOBY and PFE stock?
Key differences: Market Cap ($14.20B vs $154.67B), P/E Ratio (280.4x vs 20.0x), Revenue Growth (0.1% vs -0.0%), Gross Margin (78.2% vs 75.8%).